Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...
The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...
Acuriant Technologies has expanded its Nanostone ceramic ultrafiltration (UF) range with the launch of CUF|Flow, a high-capacity module designed to boost throughput and shrink plant footprints for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback